Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
mattiafalchetto.osti@uniroma1.it
Mattia Falchetto Osti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
mattiafalchetto.osti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy
RADIATION ONCOLOGY
2016
Adjuvant radiochemotherapy for gastric cancer. Should we use prognostic factors to select patients?
WORLD JOURNAL OF GASTROENTEROLOGY
2016
Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS
2015
Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade: In vitro study
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
2015
Adjuvant chemoradiotherapy in gastric cancer. a pooled analysis of the AIRO Gastrointestinal Group experience
TUMORI
2015
Latent tubercolosis infection in patients with cronic plaque psoriasis: evidence from the Italian Psocare Registry
BRITISH JOURNAL OF DERMATOLOGY
2015
Stereotactic body radiation therapy for liver lesions. A single-institution experience
ANTICANCER RESEARCH
2015
Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients
ANTICANCER RESEARCH
2015
Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up
ANTICANCER RESEARCH
2015
Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
ANTICANCER RESEARCH
2015
Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas
JOURNAL OF NEURO-ONCOLOGY
2015
« prima
< precedente
1
2
3
4
Progetti di Ricerca
La radioterapia stereotassica frazionata extracranica e le terapie biologiche nel trattamento delle neoplasie solide metastatiche: analisi del controllo locale e della tossicità nei trattamenti combinati.
VALUTAZIONE DI FATTORI PROGNOSTICI CLINICO-PATOLOGICI IN PAZIENTI CON ADENOCARCINOMA DELLA PROSTATA A RISCHIO INTERMEDIO ED ALTO TRATTATI CON RADIOTERAPIA CURATIVA IPOFRAZIONATA ASSOCIATA AD ORMONOTERAPIA
Radioterapia stereotassica frazionata concomitante a immunoterapia o target-therapy nel trattamento delle metastasi cerebrali.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma